Drug company gives ofatumumab update
Drug company gives ofatumumab update
Biotech firm Genmab has announced an update on development plans for ofatumumab in autoimmune indications focusing on relapsing multiple sclerosis following the transfer of the rights to ofatumumab from GlaxoSmithKline (GSK) to Novartis at the end of 2015...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1366 Views
-
Last post by frodo
-
- 0 Replies
- 1011 Views
-
Last post by frodo
-
- 0 Replies
- 2365 Views
-
Last post by NHE
-
- 0 Replies
- 1297 Views
-
Last post by frodo
-
- 0 Replies
- 1269 Views
-
Last post by frodo
-
- 0 Replies
- 1251 Views
-
Last post by frodo
-
- 0 Replies
- 1556 Views
-
Last post by NHE
-
- 0 Replies
- 478 Views
-
Last post by NHE
-
- 1 Replies
- 2983 Views
-
Last post by Tif